Urology at Changhai Hospital Shanghai | CMCS

Expert Urological Care at One of Shanghai's Premier Military Medical Centers

The Department of Urology at Changhai Hospital — affiliated with Naval Medical University (Second Military Medical University) — is one of Shanghai's most distinguished urology centers, with a national reputation for excellence in robotic and minimally invasive urological surgery, urolithiasis, prostate cancer, bladder cancer, kidney cancer, and the management of complex urological conditions. With a strong research program and a high-volume surgical practice, Changhai Hospital's urology department offers international patients access to some of China's most eminent urologists and the latest surgical techniques and medical therapies.

For international patients requiring robotic prostatectomy, kidney-sparing surgery, stone surgery, or management of a complex urological condition — Changhai Hospital's urology department offers an unparalleled combination of surgical expertise, oncological capability, and research leadership. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their urological care journey at Changhai Hospital.

About the Department

Changhai Hospital's urology department is a national key clinical specialty operating dedicated urology inpatient wards, multiple urological operating theaters with da Vinci robotic surgical systems, a urodynamics laboratory, a stone center with shock wave lithotripsy and endoscopic stone surgery, a urological oncology program, a male health clinic, and works in close collaboration with oncology, nephrology, and radiology through a fully integrated multidisciplinary team.

Faculty members publish regularly in leading urology journals including European Urology, Journal of Urology, BJU International, Urology, and World Journal of Urology.

Urolithiasis (Kidney & Ureteral Stones)

Changhai Hospital's stone center is one of China's most experienced, performing thousands of stone procedures annually:

• Shock Wave Lithotripsy (SWL) — For renal and ureteral stones ≤2cm; non-invasive outpatient procedure; electromagnetic and electrohydraulic lithotripters
• Ureteroscopy (URS) & Laser Lithotripsy — Flexible and semi-rigid URS with holmium laser and thulium fiber laser (TFL) for ureteral and renal stones; single-use digital ureteroscopes; dusting and fragmentation techniques
• Percutaneous Nephrolithotomy (PCNL) — Standard, mini, ultra-mini, and micro-PCNL for large renal stones (>2cm) and staghorn calculi; tubeless PCNL; prone and supine approaches
• Retrograde Intrarenal Surgery (RIRS) — Flexible ureteroscopy for renal stones; single-use flexible ureteroscopes
• Laparoscopic Pyelolithotomy — For complex renal stones not amenable to PCNL or URS
• Metabolic Stone Evaluation — 24-hour urine collection; stone composition analysis; dietary and pharmacological prevention; hyperparathyroidism evaluation

Urological Oncology

Prostate Cancer

• Localized Prostate Cancer — Active surveillance for low-risk disease; robotic-assisted radical prostatectomy (RARP) with nerve-sparing technique; extended pelvic lymph node dissection; focal therapy (HIFU) for selected patients
• Locally Advanced Prostate Cancer — RARP with extended PLND; adjuvant or salvage radiation; long-term ADT
• Biochemical Recurrence — PSMA PET-CT for recurrence localization; salvage radiation; ADT; enzalutamide/apalutamide for nmCRPC
• Metastatic Hormone-Sensitive Prostate Cancer — ADT + abiraterone; ADT + enzalutamide; ADT + apalutamide; ADT + darolutamide; ADT + docetaxel; triplet therapy (ARASENS)
• Metastatic CRPC — Abiraterone; enzalutamide; cabazitaxel; olaparib/rucaparib for HRR-mutated mCRPC; lutetium-177 PSMA-617 (Pluvicto); radium-223

Bladder Cancer

• Non-Muscle-Invasive Bladder Cancer (NMIBC) — TURBT with blue light cystoscopy; intravesical BCG; gemcitabine + docetaxel for BCG-unresponsive NMIBC; pembrolizumab for BCG-unresponsive CIS; nadofaragene firadenovec
• Muscle-Invasive Bladder Cancer (MIBC) — Neoadjuvant cisplatin-based chemotherapy; robotic radical cystectomy with intracorporeal neobladder or ileal conduit; trimodality bladder preservation for selected patients
• Advanced Urothelial Carcinoma — Enfortumab vedotin + pembrolizumab (EV-302); gemcitabine + cisplatin/carboplatin; avelumab maintenance; sacituzumab govitecan; erdafitinib for FGFR-altered disease

Kidney Cancer (Renal Cell Carcinoma)

• Localized RCC — Robotic partial nephrectomy for nephron-sparing surgery; zero-ischemia techniques; radical nephrectomy for larger tumors; ablative therapies (RFA, cryoablation) for small renal masses
• Metastatic RCC — Nivolumab + ipilimumab; pembrolizumab + axitinib; nivolumab + cabozantinib; lenvatinib + pembrolizumab; belzutifan for VHL-associated RCC; cabozantinib
• Adjuvant RCC — Pembrolizumab for high-risk resected RCC

Benign Prostatic Hyperplasia (BPH)

• Medical Management — Alpha-blockers; 5-alpha reductase inhibitors; combination therapy; tadalafil for BPH + ED
• Laser Surgery — Holmium laser enucleation of the prostate (HoLEP); thulium laser enucleation (ThuLEP); GreenLight laser vaporization; bipolar TURP
• Minimally Invasive Treatments — Prostatic urethral lift (UroLift); water vapor thermal therapy (Rezum)
• Robotic Simple Prostatectomy — For very large prostates (>100g)

Robotic & Minimally Invasive Urology

• Robotic-Assisted Radical Prostatectomy (RARP) — Nerve-sparing; extended PLND; one of Shanghai's most experienced RARP programs
• Robotic Partial Nephrectomy — Zero-ischemia and off-clamp techniques; renal function preservation
• Robotic Radical Cystectomy — Intracorporeal neobladder and ileal conduit
• Robotic Pyeloplasty — For UPJ obstruction
• Laparoscopic Adrenalectomy — For adrenal tumors (pheochromocytoma, aldosteronoma, adrenocortical carcinoma)

Male Health & Andrology

• Erectile Dysfunction — PDE5 inhibitors; intracavernosal injection; penile prosthesis implantation (inflatable and malleable)
• Male Infertility — Semen analysis; varicocele repair; TESA/TESE/Micro-TESE for azoospermia
• Testosterone Deficiency — Testosterone replacement therapy; monitoring

Female Urology & Pelvic Floor

• Stress Urinary Incontinence — Mid-urethral sling (TVT, TOT); Burch colposuspension
• Overactive Bladder — Antimuscarinics; beta-3 agonists (mirabegron, vibegron); botulinum toxin; sacral neuromodulation
• Pelvic Organ Prolapse — Robotic sacrocolpopexy; native tissue repair

Why International Patients Choose Changhai Urology

• High-Volume Stone Center — One of China's most experienced stone centers; full range of SWL, URS, PCNL, and RIRS
• Robotic Surgery Expertise — High-volume robotic prostatectomy, partial nephrectomy, and cystectomy
• HoLEP/ThuLEP — Laser enucleation of the prostate for BPH; superior to TURP for large prostates
• Lu-177 PSMA Therapy — Access to lutetium-177 PSMA-617 for eligible mCRPC patients
• Thulium Fiber Laser (TFL) — Next-generation laser for stone dusting and BPH treatment
• Cost-Effectiveness — World-class urological care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your urological diagnosis, PSA results, imaging (CT, MRI, PSMA PET-CT), stone CT, and prior treatment history with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate urologist based on your condition — stone disease, prostate cancer, bladder cancer, kidney cancer, BPH, or male/female urology.
4. MDT Submission — Where appropriate, we facilitate pre-arrival case review by Changhai's urological oncology MDT.
5. Priority Scheduling — We secure a consultation and surgical slot with minimal waiting time.
6. Travel & Logistics — Assistance with visa invitation letters, accommodation near Changhai Hospital, and Shanghai airport transfers.
7. Surgical Coordination — Full coordination of pre-operative assessment, robotic surgical admission, and post-operative care.
8. Post-Operative Follow-Up — Pathology report translation, treatment plan interpretation, and remote follow-up coordination after you return home.

Book a Consultation

If you have kidney stones, prostate cancer, bladder cancer, kidney cancer, BPH, or a complex urological condition — CMCS can arrange a specialist consultation with Changhai Hospital's urology team in Shanghai.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com